Prevalence of Hepatitis B and C Among Stroke Patients in Khairpur

Prevalence of Hepatitis B and C

Authors

  • Yasir Akbar Jamali Department of Physiology, University of Sindh, Jamshoro, Pakistan
  • Jawad Ahmad Department of Pharmacy, Shah Abdul Latif University, Khairpur, Pakistan
  • Mushtaq Hussain Institute of Microbiology, Shah Abdul Latif University, Khairpur, Pakistan
  • Rashid Ali Arbani Department of Pharmacy, Shah Abdul Latif University, Khairpur, Pakistan
  • Wali Muhammad Mangrio Department of Zoology, Shah Abdul Latif University, Khairpur, Pakistan
  • Sham Lal Institute of Microbiology, Shah Abdul Latif University, Khairpur, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v6i12.994

Keywords:

Hepatitis, Stroke, Virus

Abstract

Hepatitis C virus (HCV) infection is associated with a high likelihood of ischaemic cerebral stroke. Patients with HCV-related stroke tend to be younger, have fewer traditional risk factors, and have elevated levels of systemic inflammation. Objective: To investigate the correlation between hepatitis C virus (HCV) infection, hepatitis B virus (HBV) infection and their functional outcome of stroke. Methods: This cross-sectional study included 157 individuals diagnosed with all types of strokes. Every patient underwent meticulous history collection and comprehensive clinical and neurological assessment. HCV infection was diagnosed using a quantitative HCV RNA assay. Results: Out of the 157 patients, 15 (29.4 %) had Hepatitis B, and thirty-six (70.6 %) had hepatitis C, with an overall prevalence of 51 (32.5%). Among the male patients, HBV and HCV were present in 8 (27.6%) and 21 (72.4%), respectively, with an overall prevalence of 29 (56.9%) (Table 2). Similarly, among female patients, HBV and HCV were present in 7 (31.8%) and 15 (68.8%) patients, respectively, with an overall prevalence of 22 (43.1%). Conclusions: An increased prevalence of Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) has been noted in patients who have experienced a stroke. 

References

eigin VL, Norrving B, Mensah GA. Global burden of stroke. Circulation Research. 2017 Feb; 120(3): 439-48. doi: 10.1161/CIRCRESAHA.116.308413. DOI: https://doi.org/10.1161/CIRCRESAHA.116.308413

Zafar A, Al-Khamis FA, Al-Bakr AI, Alsulaiman AA, Msmar AH. Risk factors and subtypes of acute ischemic stroke: A study at king fahd hospital of the university. Neurosciences Journal. 2016 Jul; 21(3): 246-51. doi: 10.17712/nsj.2016.3.20150731. DOI: https://doi.org/10.17712/nsj.2016.3.20150731

Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infectious Diseases. 2013 Dec; 13(1): 1-21. doi: 10.1186/1471-2334-13-288. DOI: https://doi.org/10.1186/1471-2334-13-288

Restivo L, Iuliano N, Nevola R, Amelia A, Fascione MC, Adinolfi LE. T-02 chronic HCV infection and extrahepatic diseases: ischemic stroke and ischemic heart disease. Digestive and Liver Disease. 2013; (45): S13. doi: 10.1016/S1590-8658(13)60038-9. DOI: https://doi.org/10.1016/S1590-8658(13)60038-9

Lee MH, Yang HI, Wang CH, Jen CL, Yeh SH, Liu CJ et al. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke. 2010 Dec; 41(12): 2894-900. doi: 10.1161/STROKEAHA.110.598136. DOI: https://doi.org/10.1161/STROKEAHA.110.598136

Masoud MM, Sayed HA, El Masry HA, Abdelkareem SA. HCV co-infection is related to acute ischemic severity and outcome. The Egyptian Journal of Internal Medicine. 2022 Dec; 34(1): 1-4. doi: 10.1186/s43162-021-00095-4. DOI: https://doi.org/10.1186/s43162-021-00095-4

Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World Journal of Gastroenterology. 2009 Dec; 15(45): 5647. doi: 10.3748/wjg.15.5647. DOI: https://doi.org/10.3748/wjg.15.5647

Muzaffar F, Hussain I, Haroon TS. Hepatitis C: the dermatologic profile. Journal of Pakistan Association of Dermatologists. 2008; 18(3): 171-81.

Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bulletin of the World Health Organization. 1999; 77(10): 801.

Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bulletin of the World Health Organization. 2000; 78: 956-63.

Williams IT, Bell BP, Kuhnert W, Alter MJ. Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Archives of Internal Medicine. 2011 Feb; 171(3): 242-8. doi: 10.1001/archinternmed.2010.511. DOI: https://doi.org/10.1001/archinternmed.2010.511

Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nature Reviews Gastroenterology and Hepatology. 2013 Sep; 10(9): 553-62. doi: 10.1038/nrgastro.2013.107. DOI: https://doi.org/10.1038/nrgastro.2013.107

Qureshi H, Bile KM, Jooma R, Alam SE, Afrid HUR‎. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. Eastern Mediterranean Health Journal. 2010; 16:‎ 15-23. doi: 10.26719/2010.16.Supp.15. DOI: https://doi.org/10.26719/2010.16.Supp.15

Negro F. HCV causes systemic disorders that can be cured. Nature Reviews Gastroenterology and Hepatology. 2014 Feb; 11(2): 77-8. doi: 10.1038/nrgastro.2013.222. DOI: https://doi.org/10.1038/nrgastro.2013.222

Ahmed F, Irving WL, Anwar M, Myles P, Neal KR. Prevalence and risk factors for hepatitis C virus infection in Kech District, Balochistan, Pakistan: most infections remain unexplained. A cross-sectional study. Epidemiology and Infection. 2012 Apr; 140(4): 716-23. doi: 10.1017/S0950268811001087. DOI: https://doi.org/10.1017/S0950268811001087

Sheikh NS, Sheikh AS, Sheikh AA, Yahya S, Lateef M. Sero-prevalence of hepatitis B virus infection in Balochistan Province of Pakistan. Saudi Journal of Gastroenterology. 2011 May; 17(3): 180. doi: 10.4103/1319-3767.80380. DOI: https://doi.org/10.4103/1319-3767.80380

Channa NA and Khan H. Risk factors for hepatitis C disease in Tando Allahyar, Pakistan: a case-control study. Bangladesh Journal of Medical Science. 2011 Jul; 10(3). doi: 10.3329/bjms.v10i3.8359. DOI: https://doi.org/10.3329/bjms.v10i3.8359

Felisberto M, Saretto AA, Wopereis S, Machado MJ, Spada C. Prevalence of HCV infection in a prison population of the greater Florianópolis area. Revista da Sociedade Brasileira de Medicina Tropical. 2019 Jul; 52. doi: 10.1590/0037-8682-0143-2019. DOI: https://doi.org/10.1590/0037-8682-0143-2019

Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age‐specific antibody to HCV seroprevalence. Hepatology. 2013 Apr; 57(4): 1333-42. doi: 10.1002/hep.26141. DOI: https://doi.org/10.1002/hep.26141

Javed N and Naz S. Prevalence of Hepatitis B infection in married women of child bearing age in district Islamabad. Gomal Journal of Medical Sciences. 2013; 11(2).

Nazar H, Nadia N, Shazia N, Zulfiqar A, Farhat A. Prevalence of Hepatitis B and Hepatitis C in blood donors of Karachi. Biomedica. 2008 Jul; 24(9): 116-7.

Uddin MS, Islam MN, Khan ME, Yeasmin S, Ahmed F, Amiruzzaman M. Frequency of hepatitis B and C viral infection among the medical waste handlers. Bangladesh Journal of Infectious Diseases. 2017; 4(1): 3. doi: 10.3329/bjid.v4i1.37673. DOI: https://doi.org/10.3329/bjid.v4i1.37673

Downloads

Published

2023-12-31
CITATION
DOI: 10.54393/pbmj.v6i12.994
Published: 2023-12-31

How to Cite

Jamali, Y. A., Ahmad, J., Hussain, M., Arbani, R. A., Mangrio, W. M., & Lal, S. (2023). Prevalence of Hepatitis B and C Among Stroke Patients in Khairpur : Prevalence of Hepatitis B and C . Pakistan BioMedical Journal, 6(12), 58–61. https://doi.org/10.54393/pbmj.v6i12.994

Issue

Section

Original Article

Plaudit